Awarded
BRIVIACT 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION 5 ML
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- UCB PHARMA, S.A
- Contract value
- €69,930Framework value — excluded from market-size totals because it is restated on every lot.
- Bids received
- 1
- Published
- 3 Sept 2026
- Awarded
- 28 Aug 2026
- Contract start
- 28 Aug 2026
- Contract end
- 12 Sept 2027estimated
- Region
- Madrid